TRVI
Trevi Therapeutics Inc
Clinical-stage biopharmaceutical company
CUSIP: 89532M101HealthcareUS1 holder
Total Value
$8.44M
Total Shares
1.54M
Net Share Change
-1.68M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$8.44M1.54M shares
TRIM-1.68M(-52.2%)